Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17429
Country/Region: Lesotho
Year: 2016
Main Partner: Population Services International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USDOD
Total Funding: $608,574 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $422,704
Testing: HIV Testing and Counseling (HVCT) $12,618
Treatment: Adult Treatment (HTXS) $172,770
Treatment: Pediatric Treatment (PDTX) $482
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: 1-9 2017 245
HTS_TST Age/sex: 10-14 Female 2017 14
HTS_TST Age/sex: 10-14 Male 2017 978
HTS_TST Age/sex: 15-19 Female 2017 140
HTS_TST Age/sex: 15-19 Male 2017 1,571
HTS_TST Age/sex: 20-24 Female 2017 162
HTS_TST Age/sex: 20-24 Male 2017 1,834
HTS_TST Age/sex: 25-49 Female 2017 138
HTS_TST Age/sex: 25-49 Male 2017 1,559
HTS_TST Age/sex: 50+ Female 2017 23
HTS_TST Age/sex: 50+ Male 2017 262
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 24
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,199
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 463
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 5,240
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 6,926
HTS_TST Service Delivery Point (Facility): Outpatient 2017 1,088
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 86
HTS_TST Service Delivery Point (Facility): VCT 2017 1,260
HTS_TST Service Delivery Point (Facility): VMMC 2017 4,492
HTS_TST Sum of Age/Sex disaggregates 2017 6,681
HTS_TST Sum of Aggregated Age/Sex <15 2017 1,223
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 5,703
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 6,926
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 6
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 9
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 16
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 63
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 24
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 95
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 28
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 110
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 11
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 48
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 6
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 4
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 17
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 79
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 316
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 6
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 120
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 9
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 180
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 500
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 315
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 344
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 310
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 34
TB_SCREENDX Screen Result: Screened Positive for TB 2017 207
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 451
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 676
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 8
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 12
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 1,147
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 10
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 190
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 15
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 285
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 500
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 500
TX_CURR Aggregated Age/Sex: <15 Female 2017 13
TX_CURR Aggregated Age/Sex: <15 Male 2017 19
TX_CURR Aggregated Age/Sex: 15+ Female 2017 752
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,128
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 1,912
TX_CURR Sum of Aggregated Age/Sex <15 2017 32
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 1,880
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 1,912
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 1
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 1
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 146
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 218
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 366
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 366
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 124
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 185
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 311
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 364
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 146
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 216
VMMC_CIRC By Age: 10-14 2017 1,101
VMMC_CIRC By Age: 15-19 2017 531
VMMC_CIRC By Age: 20-24 2017 1,594
VMMC_CIRC By Age: 25-29 2017 531
VMMC_CIRC By Age: 30-49 2017 551
VMMC_CIRC By Age: 50+ 2017 184
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 4,492
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 4,492
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 4,492
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 3,410
Cross Cutting Budget Categories and Known Amounts Total: $20,000
Condoms: Commodities $10,000
Condoms: Policy, Tools, and Services $10,000